Randomized clinical trial |
- Considered the gold standard for analyzing therapeutic interventions - The study groups differ only in terms of the intervention factor: there is direct inference of causality - Ideally, it is able to control selection bias and confounders that can affect the study outcome |
- Expensive and time consuming - Not always feasible for ethical reasons - The absence of blinding, especially when it cannot be applied, may directly affect the study result - Subject to loss of patients during follow-up - Generally evaluates specific disease scenarios - Frequently conducted in academic scenarios, limiting the generalizability of the data |
Nonrandomized clinical trial |
- Performed when an RCT would be ideal but is not possible (due to cost or unacceptability to patients or managers) - Generally more practical than RCT - Used when attempting to demonstrate the efficacy of a new treatment (phase IV studies) |
- Sample group is determined by convenience - Causality is not directly inferred - The effect of confounders may not be obvious |
Before-and-after study |
- Quick and easy to conduct - May be used to compare the ICU data or variables of a specific patient before and after an intervention is instituted - Useful in interventions that are difficult to perform using a clinical trial (e.g., to evaluate the efficacy of isolation measures in the transmission of nosocomial infections by multiresistant germs) |
- Subject to the Hawthorne effect - Simultaneous interventions may alter the studied outcome and the interval between the measurement of outcomes - Subject to the “regression toward the mean” phenomenon |
Cross-sectional study |
- Measures the prevalence of a particular outcome - One of the first stages in investigating the cause of disease outbreaks - May be used to analyze frequencies of risk factors and study outcomes - Low cost and easy to conduct |
- Measures of exposure and disease are performed at the same time, which reduces the study’s ability to establish a causal association (association does not necessarily imply causation) - Difficult to use for investigating low-prevalence conditions - Appropriate when evaluating diagnostic tests or disease outbreaks |
Case series |
- The characteristics of the study population are related - Useful when characterizing rare disease scenarios with a diagnosis or treatment that is not clearly established in the literature (for example: the characterization of outbreaks of rare micro-organisms) |
- There is no comparison group (reference) - Sampling is not representative of the studied population - Causal associations cannot be evaluated |
Case-control |
- Cheaper and faster (than cohort studies) - Useful when investigating disease causes, especially when the incidence of the outcome (disease) is rare or has a long latency period, as the starting point is the outcome and a retrograde analysis of risk factors is performed |
- There is no way of knowing the incidence of the disease - Prone to sampling bias among both cases and controls and to observation and recording bias |
Cohort |
- Provides the best information about the etiology, incidence and natural history of a disease by starting with risk factors and analyzing subsequent outcomes - Useful when risk factors have a low prevalence - A cohort study should be used when it is not possible to conduct an RCT for ethical reasons |
- Expensive and requires long periods of observation - Subject to loss to follow-up - Unable to control all confounders - Subject to discontinuity of patient follow-up - Frequently presents results that are discordant with those of RCT that analyze the same research question |
Systematic review with meta-analysis |
- Clinical research with the lowest evidence level - Summarizes the results of primary studies using strategies that decrease the occurrence of random and systematic errors |
- The quality of a meta-analysis depends on the quality of the studies it includes - The greater the heterogeneity of the included studies, the lower the reliability of the result obtained |